Editorial Policy

Absolute Prohibitions

HRT Pharmacopoeia will never publish any of the following:

Avoid absolutes: prefer “we suggest / typically / in most cases” over “must / always / never”
Address the reader directly: write “you can choose A or B” rather than “patients should choose A”
State uncertainty plainly: conclusions at evidence level B/C/X must be tagged with “data are limited” or “expert opinion”
Reduce stigma: use community-affirming language and avoid outdated or overly clinical terms

Every medical claim is sourced via the CitationRef component (IDs map to entries in src/data/references.json)
DOIs are preferred; where no DOI exists, cite journal publication info plus a stable URL
Figures and diagrams are original or sourced from Creative Commons / public domain works; reproductions are credited
Original site content is released under CC BY-SA 4.0; code is governed by the repository LICENSE

Readers can submit reports via the feedback form or GitHub Issues:

Type	Response time	Handling
Factual error	Initial reply within 72 hours	Erratum notice at the top of the page + change log
Citation drift	72 hours	Replace the citation and publish a public correction log
Outdated information	7 days	Incremental update + refresh `lastReviewed`
Dangerous advice	24-hour emergency takedown	Repair or keep offline pending review

Major corrections are also propagated to:

Content complaints: feedback form
Legal / copyright: open a GitHub Issue with the legal label, or contact the repository maintainers
Privacy: this site does not collect personally identifiable information; any reported privacy leak is handled within 24 hours

No commercial sponsorship, no drug advertising, no purchase commissions
Operating costs are covered by volunteer contributions and open-source community donations
Editors and medical advisors sign conflict-of-interest disclosures; topics with directly related prescribing or commercial relationships are recused
No external links carry affiliate identifiers; only community-vetted hospital and hotline resources are listed

Page type	Default review interval
Emergency recognition, dosing red lines, danger warnings	6 months
Drug monographs and guides	12 months
Tools, policies, methodology	12 months
Blog posts	Verified once 12 months after publication

A major guideline change (EMA/FDA safety alert, new WPATH / Endocrine Society edition) triggers an incremental update within 48 hours.